Monoclonal antibody BW494

Drug Profile

Monoclonal antibody BW494

Latest Information Update: 16 Sep 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pancreatic cancer

Most Recent Events

  • 09 Sep 1996 New profile
  • 09 Sep 1996 Discontinued-II for Pancreatic cancer in Germany (IV-infusion)
  • 09 Sep 1996 Discontinued-II for Pancreatic cancer in Netherlands (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top